An interventional study of Tongue Strength Assessment and Polysomnography in Obstructive Sleep Apnea, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 4 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-07-30.
Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Sleep Apnea, Obstructive by Hospices Civils de Lyon — 6 open to participants now, 7 under way, none of them phase 3. Sleep Apnea, Obstructive · Hospices Civils de Lyon.
Among the 11 studies in Sleep Apnea, Obstructive by Hospices Civils de Lyon, this one is one of 6 that started in 2026, is one of 7 with no phase, and was the 8th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →6 of the 11 studies in Sleep Apnea, Obstructive by Hospices Civils de Lyon are open now, in 1 country. Recruiting first, the newest first:
Hospices Civils de Lyon · Sites in France
Ages 4–17
Hospices Civils de Lyon · Sites in France
Ages 5 mo–6 mo
Hospices Civils de Lyon · Sites in France
Ages 23 days–38 days
Hospices Civils de Lyon · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 4 Years to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 6 started in 2026.
This study's planned enrollment of 78 is above the median of 52 across 1,476 interventional studies indexed under Sleep Apnea, Obstructive.
Median enrollment 62 across the 7 interventional studies, 67 across the 4 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Hospices Civils de Lyon is the lead sponsor of 1,868 studies on the registry; 447 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Sleep Apnea, Obstructive by Hospices Civils de Lyon, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Obstructive sleep apnea (OSA) is part of the sleep-disordered breathing spectrum. Its prevalence in children is 1-5%, and it can have negative consequences at the cardiovascular, cognitive as well as behavioral levels. In children, the first-line treatment is adenotonsillectomy. However, residual obstructive events can persist as the success rate of surgery reaches only 49% in non-obese children. Residual OSA may be explained by multiple sites of obstruction, found in 20-85% children concerned by persistent OSA. Indeed, the tongue appears among one possible primary sites of obstruction. Given the tongue's crucial role in upper-airway patency during sleep, its assessment can inform us about the myofunctional deficits involved in sleep-disordered breathing.
The primary objective of the present study is to assess tongue motor functions in children with sleep-disordered breathing and to compare them to those of healthy children (data collected in a current study (TMAC) conducted at UCLouvain, Belgium; NCT06166680), in order to document possible myofunctional deficits in children with OSA. The hypothesis is that tongue motor functions will be lower in children with sleep-disordered breathing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Regarding patients with suspected OSA type I or II:
Regarding patients with suspected OSA type III:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Children aged 4 to 17 years old, referred to the sleep clinic for polysomnography in a context of suspected OSA
Other: Tongue Strength Assessment · Diagnostic Test: Polysomnography · Other: Subjective Assessment of Sleep-Disordered Breathing · Other: Subjective Assessment of Daytime Functioning · Other: Anthropometry · Other: Clinical Examination · Other: Orofacial Praxis Assessment
The following items will be assessed: 1. Tongue peak pressure during 3 seconds of tongue protrusion 2. Tongue peak pressure (i.e., the maximal pressure - Pmax - exerted against the IOPI bulb) during 3 seconds of tongue elevation 3. Tongue pressure (in kPa) exerted against the IOPI (Iowa Oral Performance Instrument) bulb while swallowing
Patients will undergo full-night polysomnography (including the JAWAC system to record mandibular movements) in the sleep unit of Hôpital Femme-Mère-Enfant (Bron, France) to explore OSA.
The following questionnaires will be filled out: * OSA-18 * Pediatric Sleep Questionnaire (PSQ) * Spruyt \& Gozal * Sleep Disturbance Scale for Children * Abreu et al.'s questionnaire
The following questionnaires will be filled out: * Epworth Sleepiness Scale * Conners
The following measures will be collected via the Quick Tongue-Tie Assessment tool: 1. Maximal mouth opening 2. Maximal mouth opening with tongue to palate
The following variables will be collected during a clinical examination: 1. Age 2. Sex 3. Weight 4. Height 5. BMI 6. Friedman score 7. Mallampati score 8. Medical history
Bucco-Linguo-Facial Motor Skills will be assessed through the test "Motricité Bucco-Linguo-Faciale" (MBLF).
Tongue peak pressure during protrusion
Tongue peak pressure during protrusion will be measured using the IOPI (Iowa Oral Performance Instrument) device. Higher tongue pressure is considered a better outcome.
Time frame: Day 1
Tongue peak pressure during elevation and swallowing
Tongue peak pressure during elevation and swallowing movements will be measured using the IOPI (Iowa Oral Performance Instrument) device. Higher tongue pressure is considered a better outcome.
Time frame: Day 1
Tongue mobility restriction
Assessed through the ratio between maximal mouth opening and maximal mouth opening with tongue to palate, measured using the Quick Tongue-Tie Assessment tool. Higher values are considered a better outcome.
Time frame: Day 1
Orofacial praxis
Orofacial praxis will be assessed through the Motricité Bucco-Linguo-Faciale (MBLF) test, which ranges from 0 to 111. Higher scores indicate a better outcome.
Time frame: Day 1
Obstructive apnea-hypopnea index (OAHI)
Respiratory parameters will be assessed by night polysomnography. A higher index indicates a worse outcome.
Time frame: Day 1
Central apnea-hypopnea index
Respiratory parameters will be assessed by night polysomnography. A higher index indicates a worse outcome.
Time frame: Day 1
Mixed apnea-hypopnea index
Respiratory parameters will be assessed by night polysomnography. A higher index indicates a worse outcome.
Time frame: Day 1
Respiratory effort index
Respiratory parameters will be assessed by night polysomnography. A higher index indicates a worse outcome.
Time frame: Day 1
Respiratory effort-related arousal index (RERA)
Respiratory parameters will be assessed by night polysomnography. A higher index indicates a worse outcome.
Time frame: Day 1
Mean CO2
Respiratory parameters will be assessed by night polysomnography.
Time frame: Day 1
Max CO2
Respiratory parameters will be assessed by night polysomnography.
Time frame: Day 1
Time spent with CO2 > 50mmHg
Respiratory parameters will be assessed by night polysomnography.
Time frame: Day 1
Mean SpO2
Respiratory parameters will be assessed by night polysomnography.
Time frame: Day 1
Desaturation index ≥ 3%
Respiratory parameters will be assessed by night polysomnography.
Time frame: Day 1
Desaturation index ≥ 4%
Respiratory parameters will be assessed by night polysomnography.
Time frame: Day 1
Time spent with SaO2 < 90%
Respiratory parameters will be assessed by night polysomnography.
Time frame: Day 1
Total sleep time
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Sleep onset latency
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Wake after sleep onset
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Duration of sleep N1
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Duration of sleep N2
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Duration of sleep N3
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Duration of REM sleep
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Sleep efficiency
Sleep architecture parameters will be assessed by night polysomnography.
Time frame: Day 1
Score on Abreu's Questionnaire
Total score ranges from 0 to 16. Higher scores indicate a worse outcome.
Time frame: Day 1
Score on the OSA-18 Questionnaire
This questionnaire assesses quality of life associated with sleep-disordered breathing in children. Total score ranges from 18 to 126. Higher scores indicate a worse outcome.
Time frame: Day 1
Score on the Pediatric Sleep Questionnaire
This questionnaire assesses symptoms and repercussions of sleep-disordered breathing in children. Total score ranges from 0 to 22. Higher scores indicate a worse outcome.
Time frame: Day 1
Score on the Spruyt & Gozal Questionnaire
This questionnaire assesses sleep-disordered breathing in children. Total score ranges from 0 to 4. Higher scores indicate a worse outcome.
Time frame: Day 1
Score on the Sleep Disturbance Scale for Children
This questionnaire assesses sleep disturbance in children. Total score ranges from 25 to 125. Higher scores indicate a worse outcome.
Time frame: Day 1
Score on the French Version of the Sleepiness Scale for Adolescents
This questionnaire assesses excessive daytime sleepiness. Total score ranges from 25 to 125. Higher scores indicate a worse outcome.
Time frame: Day 1
Score on the Conners Rating Scale
This questionnaire assesses hyperactivity. Total score ranges from 0 to 30. Higher scores indicate a worse outcome.
Time frame: Day 1
Medical history
Medical history is conducted by a doctor. It will be used to determine the type of OSA (craniofacial and/or syndromic comorbidities classify OSA as type III; otherwise, OSA is type II in the presence of obesity, or type I in the absence of obesity).
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Mar 2028, 24 months after the start.
Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 24 months is below that.
Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.